Wrongly granted patents and Accountability of patent offices

Often the continuous increase in patent applications and grants of patents in developed and some developing countries (mostly China) is eulogized as an attestation of the growing innovation, research and development, and the role of the patent system in stimulating it. However, an increase in multiple grants of patents to individual pharmaceutical products indicates to a great extent that low standards of patentability criteria are applied to grant patents by patent offices and courts. For instance, multiple patents granted to purported potential COVID-19 drug Remdesivir have extended its monopoly for 6 years (2035) in a few countries. Patent offices in developing countries play an important role in applying rigorous and high-quality patent examination and ensuring access to medicines. The panel discussion will focus on the accountability of patent offices in applying high-quality examination and weeding out unworthy patent.

This session has simultaneous interpretation in Spanish, English and Portuguese.

Include this session in your calendar. Below you will find a link so you can add it.

Enter the session at https://us02web.zoom.us/j/81309651943

Participation during and after the session will take place through Telegram. Join the group for this session at https://t.me/joinchat/P11BVxjsrbWw41nVuyTKiA

We recommend that you read our Conduct Guide beforehand at http://www.globalcongressip.org/2020/09/29/conduct-guide/